LFVN
NASDAQLifevantage Corporation
SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
Price$6.00-0.00 (-0.08%)
01:45 PM07:45 PM
News · 26 weeks36-22%
2026-04-192026-10-11
Mix2490d
- Insider10(42%)
- SEC Filings7(29%)
- Other3(13%)
- Earnings2(8%)
- Leadership1(4%)
- Dividends1(4%)
Latest news
25 items- PRLifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company") today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan. The awards were granted pursuant to the key executive benefits agreement between the Company and Mr. Moorehead, dated as of April 15, 2026, as an inducement material to Mr. Moorehead’s employment in accordance with Nasdaq Listing Rule 5635(c)(4). The awards were granted on October 7, 2026 and consist of (i) a grant of restricted stock units ("RSUs") representing 1
- INSIDERSEC Form 4 filed by Lifevantage Corporation4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Lifevantage Corporation4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Lifevantage Corporation4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Lifevantage Corporation4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Lifevantage Corporation4 - Lifevantage Corp (0000849146) (Issuer)
- SECSEC Form 8-K filed by Lifevantage Corporation8-K - Lifevantage Corp (0000849146) (Filer)
- SECSEC Form DEFA14A filed by Lifevantage CorporationDEFA14A - Lifevantage Corp (0000849146) (Filer)
- SECSEC Form DEF 14A filed by Lifevantage CorporationDEF 14A - Lifevantage Corp (0000849146) (Filer)
- PRLifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026. The webcast of the presentation will begin at approximately 1:30 p.m. Eastern Time on Wednesday, September 23, 2026. The event is open access for all investors and interested parties can register through the Company’s Investor Relations website at https://investor.lifevantage.com/
- INSIDERDirector Lewis Darwin bought $6,071 worth of shares (976 units at $6.22), increasing direct ownership by 0.71% to 138,244 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERChief Sales Officer Cunningham Kristen covered exercise/tax liability with 2,254 shares and sold $55,649 worth of shares (9,001 units at $6.18), decreasing direct ownership by 9% to 120,162 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERChief Financial Officer Aure Carl covered exercise/tax liability with 1,869 shares, decreasing direct ownership by 1% to 156,495 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- SECSEC Form 10-K filed by Lifevantage Corporation10-K - Lifevantage Corp (0000849146) (Filer)
- SECLifevantage Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Lifevantage Corp (0000849146) (Filer)
- PRLifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026. Fourth Quarter Fiscal 2026 Summary*: Revenue was $42.4 million, a decrease of 23.1% from the prior year period;Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;Net income per diluted share was $0.10, versus $0.15 per diluted share a year ago;Adjusted earnings per diluted share was $0.11, compared to $0.17 a year ago; andAdjusted EBITDA was $2.7 million co
- PRLifeVantage Declares Quarterly DividendSALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our pr
- PRLifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approxi
- PRLifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company") today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s new President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan (the "New Employee Plan") as an inducement material to Mr. Moorehead’s employment in accordance with Nasdaq Listing Rule 5635(c)(4). The awards were granted on August 6, 2026 and consist of (i) a grant of restricted stock units ("RSUs") representing 308,642 shares of the Company’s common stock, which will vest in three equal annual installments starting on the
- INSIDERPresident and CEO Moorehead Terrence was granted 308,642 shares (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 3 filed by new insider Moorehead Terrence3 - Lifevantage Corp (0000849146) (Issuer)
- PRLifeVantage Welcomes Terrence Moorehead as Chief Executive OfficerSALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced Terrence Moorehead has officially joined the Company as President and Chief Executive Officer and as a member of the Board of Directors. Moorehead’s appointment was previously announced on April 16, 2026. Moorehead brings over 25 years of global leadership experience in consumer wellness, brand transformation, and digital modernization. He most recently served as President and CEO of Nature’s Sunshine Products, where he led a multi-ye
- SECLifevantage Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Lifevantage Corp (0000849146) (Filer)
- SECSEC Form S-8 filed by Lifevantage CorporationS-8 - Lifevantage Corp (0000849146) (Filer)
- INSIDERChief Financial Officer Aure Carl covered exercise/tax liability with 1,361 shares, decreasing direct ownership by 0.87% to 155,554 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
LFVN FAQ
7 questionsWhat does Lifevantage Corporation do?
LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a...Where does LFVN stock trade?
Lifevantage Corporation (LFVN) is listed on NASDAQ.What sector and industry is LFVN in?
Lifevantage Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.Does LFVN pay a dividend?
LFVN's most recent ex-dividend date was 2026-09-01 with a cash dividend of $0.05 per share. No future ex-date is on file yet.What are analysts saying about LFVN?
Lifevantage Corporation has had 2 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $3500.00 price target on 2025-01-14. Recent price targets range from $2600.00 to $3500.00.What companies are similar to LFVN?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare LFVN side-by-side with any of them on Quantisnow.How can I track LFVN on Quantisnow?
Quantisnow aggregates Lifevantage Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LFVN to receive live email and push alerts on every new disclosure.